Squarepoint’s Axcelis ACLS Stock Holding History

Squarepoint’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.64M	Buy	19,200 +16,200	+540%	+$2.4M	﹤0.01%	1857
2026 Q1	$279K	Buy	+3,000	New	+$266K	﹤0.01%	3764

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Squarepoint's ACLS Position: Q2 2026 in Review

Squarepoint sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 33,291 shares — an estimated $4.94M sold.

Squarepoint first reported a position in ACLS in Q4 2016 and held it in 28 quarters. The position peaked at $12.6M in Q3 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

Squarepoint reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
Squarepoint sold 33,291 Axcelis shares in Q2 2026, an estimated $4.94M.
Squarepoint first reported a position in Axcelis in Q4 2016 and held it in 28 quarters.
Squarepoint's Axcelis position peaked at $12.6M in Q3 2025.
441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.